Top Biotech Short Squeeze Stocks

by Fred Fuld III

Last week was the worst performing of the year for stocks, so far. Especially for the biotech stocks.

This may create a buying opportunity for biotech stocks that are heavily shorted.

Do short squeeze stocks actually go up?

On August 22, 2022, I posted an article about meme related short squeeze stocks, and pointed out Bed Bath and Beyond (BBBY) after it had its big run-up. In exactly one week after the article was posted, the stock jumped by more than 43%.

Another stock that was mentioned was Intercept Pharmaceuticals, Inc. (ICPT), which increased by almost 5% in just two days.

The stock with the biggest short ratio (days to cover), at 14.3 back then, was Heron Therapeutics, Inc. (HRTX). It rose by 9.5% in three days.

When you short a stock, it means that your goal is to make money from a drop in the price of a stock. Technically, what happens is that you borrow shares of a stock, sell those shares, then buy back those shares at a hopefully lower price so that those shares can be returned. This all happens electronically, so you don’t actually see all the borrowing and returning of shares; it just shows up on your screen as a negative number of shares.

Short sellers can be profitable, but sometimes when the stock moves against them, and begins to rise, the short sellers jump in right away to buy shares to cover their positions, creating what is called a short squeeze. When a short squeeze takes place, it can cause the share prices to increase fast and furiously. Any good news can trigger the short squeeze.

Some traders utilize this situation by looking for stocks to buy that may have a potential short squeeze. Here is what a short squeeze trader should take into consideration:

Short Percentage of Float ~ The float is the number of freely tradable shares and the short percentage is the number of shares held short divided by the float. Amounts over 10% to 20% are considered high and potential short squeeze plays.

Short Ratio / Days to Cover / Short Interest Ratio -This is probably the most important metric when looking for short squeeze trades, no matter what you call it. This is the number of days it would take the short sellers to cover their position based on the average daily volume of shares traded. This is a significant ratio as it shows how “stuck” the short sellers are when they want to buy in their shares without driving up the price too much. Unfortunately for the shortsellers, the longer the number of days to cover, the bigger and longer the squeeze.

Short Percentage Increase ~ This is the percentage increase in in the number of short sellers from the previous month.

The following are some heavily shorted tech stock that may be worth considering.

CompanySymbolShort % of FloatShort % ChangeShort Interest Ratio
NovavaxNVAX43% 0% 4.5
ImmunitybioIBRX29%6%14
PMV PharmaceuticalsPMVP29%-4%16.5
SpringWorks TherapeuticsSWTX30%-2%16.5

The second stock on the list, Immunitybio (IBRX), which develops  therapies and vaccines that amplify the immune system to defeat cancers and infectious diseases, has about 29% of its float shorted, an increase of 6% over last month.

The short interest ratio is 14, which means that it would take the short sellers 14 days to cover their position, based on recent average volume.

Just keep in mind that just because a stock has good earnings ratios and is heavily shorted, doesn’t mean that the stock will go up, especially in a bear market. Also, stocks that are significantly shorted may be shorted for a reason.

Disclosure: Author didn’t own any of the above at the time the article was written.

Top Sports Betting Stocks

by Fred Fuld III

In 2018,  the Supreme Court came decided that betting on sports in all states is legal, with each state to determine whether or not to allow this form of gambling.

Sports betting is now legal in 36 states.

According to a report last September from Morgan Stanley, “By 2025, sports betting revenue could eclipse $7 billion.”

So betting on sports is a major growing business, which will eventually be very granular in terms of available bets. For example, with the net pitch be a ball or a strike.

Of course, the major casino companies are involved in this industry, such as Caesars Entertainment Inc. (CZR) and MGM Resorts International(MGM), however there are few pure plays.

For example there is Flutter Entertainment (PDYPY) and DraftKings (DKNG).

For more diversification, there is a sports betting ETF, the Roundhill Sports Betting & iGaming ETF (BETZ).

Flutter Entertainment, which was formerly Paddy Power Betfair, is based in Dublin, Ireland. The company owns FanDuel, Paddy Power, Betfair, Fox Bet, Full Tilt Poker and PokerStars

The stock trades Over-the-Counter in the United States and has a $25.7 billion market cap. It is currently negative earnings.

Boston, Massachusetts based DraftKings, a provider of sports betting and daily fantasy sports, originally went public through a SPAC.

The stock has a market cap of $8.2 billion and trades on NASDAQ. Earnings are currently negative.

However, the quarterly revenue growth year-over-year is 80.7%. It has $3.76 in cash per share.

Maybe a bet on one of these stocks will provide a winner for your portfolio.

Disclosure: Author didn’t own any of the above at the time the article was written.


Stocks Going Ex Dividend in March 2023

The following is a short list of some of the many stocks going ex dividend during the next month.

Many traders and investors use the stock trading technique called ‘Buying Dividends,’ also commonly referred to as ‘Dividend Capture.’ This is the strategy of buying stocks before the ex dividend date and selling the stock shortly after the ex date at about the same price, yet still being entitled to the dividend.

This technique generally works in bull markets and flat or choppy markets, but during bear markets, you may want to consider avoiding this strategy. In order to be entitled to the dividend, you have to buy the stock before the ex-dividend date, and you can’t sell the stock until on or after the ex date.

The actual dividend may not be paid for another few weeks.

WallStreetNewsNetwork.com has compiled a downloadable list of the stocks going ex dividend in the near future. The list contains many dividend paying companies, lots with market caps over $500 million. Some of the stocks have yields over 2%. Here are a few examples showing the stock symbol, the ex-dividend date, the periodic dividend amount, and the annual yield.

Goldman Sachs Group, Inc. (GS)3/1/20232.502.75%
Nike, Inc. (NKE)3/3/20230.341.15%
Southwest Airlines Company (LUV)3/7/20230.182.14%
Waste Management, Inc. (WM)3/9/20230.701.85%
Merck & Company, Inc. (MRK)3/14/20230.732.66%
Coca-Cola Company (KO)3/16/20230.463.06%
DTE Energy Company (DTE)3/17/20230.9523.37%
Portland General Electric Co. (POR)3/24/20230.4523.73%
ConocoPhillips (COP)3/28/20230.602.20%
Xerox Holdings Corporation (XRX)3/30/20230.256.15%
Wolverine World Wide, Inc. (WWW)3/31/20230.102.37%

The entire list of over 100 ex-dividend stocks will be emailed to all subscribers next week. If you are not a subscriber, you can sign up at the signup box below. Don’t miss out. Remember, it’s free!

Dividend Definitions

Declaration date: the day that the company declares that there is going to be an upcoming dividend.

Ex-dividend date: the day on which if you buy the stock, you would not be entitled to that particular dividend; or the first day on which a shareholder can sell the shares and still be entitled to the dividend.

Record date: the day when you must be on the company’s books as a shareholder to receive the dividend. The ex-dividend date is normally set for stocks at two business days before the record date.

Payment date: the day on which the dividend payment is actually made, which can be as long at two months after the ex date.

Don’t forget to reconfirm the ex-dividend date with the company before implementing this technique.

Disclosure: Author did not own any of the above at the time the article was written; affiliate links are on this page.

Top Space Exploration Stocks

by Fred Fuld III

According to Morgan Stanley, “Global space could be a $1 trillion industry by 2040.” .

Have you ever thought about traveling to the moon or Mars? You now have that opportunity.

For example, Elon Musk’s SpaceX is selling tickets to travel around the Earth. Richard Branson’s Virgin Galactic (SPCE) plans to to provide suborbital spaceflights to space tourists.. Jeff Bezos, founder of Amazon (AMZN) has created Blue Origin for space tourists.

If you are looking for individual stocks, here are several you might want to consider:

•Virgin Galactic Holdings (SPCE)

•Maxar Technologies (MAXR)

•Aerojet Rocketdyne (AJRD)

•Rocket Lab USA (RKLB)

•Momentus (MNTS)

•Virgin Galactic Holdings (SPCE) is developing commercial spacecraft to provide suborbital spaceflights to space tourists. It was originally a SPAC stock.

Last year, Virgin Galactic announced that it opens ticket sales to the public, with the price of a reservation at $450,000.

The company is currently negative earnings, although long term annual growth estimate for earnings over the next five years is 19.4%.

Maxar Technologies (MAXR) designs and manufactures satellites and spacecraft components, especially those used in high-resolution satellite imagery.

The stock has a forward price to earnings ratio of 32, with an earnings per share growth this year of 183%, and an EPS growth next year of 379%.

A better alternative might be to allocate your funds to one of the space ETFs.

The exchange traded fund Direxion Moonshot Innovators ETF (MOON), which is up 23.91% so far this year. It has an expense ratio of 0.65 and pays a yield of 2.43%.

Procure Space ETF (UFO), founded in 2019, has increased by 6.39% this year. The expense ratio is 0.75, and the yield is 2.94%.

SPDR Kensho Final Frontiers ETF (ROKT) has been around since 2018. It is up 8.48% so far this year, but it also pays a yield of 0.5%. It has an expense ratio of o.45.

The youngest space ETF on the block is ARK Space Exploration & Innovation ETF (ARKX), which went public recently. The fund is up 14.17 year-to-date, and th expense ratio is 0.7%.

Hopefully, one of these stocks or ETFs will take your portfolio to the moon.

Disclosure: Author owns AMZN.

Top CRISPR Stocks

by Fred Fuld III

You may have seen it on the cover of Time Magazine, you may have watched the episode on 60 Minutes.

CRISPR.

So what is CRISPR?

The acronym CRISPR means “clustered regularly interspaced short palindromic repeats”. What this means simply is that it is a technique for editing and splicing DNA much more quickly, simply, and less expensively than what was done previously. It is a revolutionary technique that could potentially cure any genetic disease.

There are several publicly traded companies that are in the CRISPR arena, both big and small. Obviously, the CRISPR technology industry is at its very early stages, so there are risks involved with some of the purer plays, none of which are currently generating earnings. Here are some of the pure plays.

Editas Medicine (EDIT) is a Cambridge, Massachusetts based genome editing company, focusing on treating patients with genetically defined diseases through the development of a proprietary genome editing platform based on CRISPR/Cas9 technology. The company sports a market cap of a bit over $687 million, and is debt free with $5.97 in cash per share.

Intellia Therapeutics (NTLA) is another pure play CRISPR stock, and has been collaborating with Novartis (NVS). Intellia is developing in vivo projects which target liver diseases, including transthyretin amyloidosis, alpha-1 antitrypsin deficiency, hepatitis B virus, and inborn errors of metabolism; and ex vivo relating to chimeric antigen receptor T cell and hematopoietic stem cell product candidates. The stock has a market cap of $3.43 billion, cash per share of $9.66, and has no long term debt.

CRISPR Therapeutics (CRSP) is a Swiss company which is developing transformative gene-based medicines for the treatment of serious human diseases using its regularly interspaced short palindromic repeats associated protein-9 (CRISPR/Cas9). It has a market cap of $3.96 billion, is debt free and has cash per share of $23.85.

CRISPR is a narrow niche of the biotechnology industry, but it could become the fastest growing and most significant of all the biotech businesses.

Disclosure: Author didn’t own any of the above at the time the article was written.

Top Quantum Computing Stocks

by Fred Fuld III

So what is quantum and why is it necessary?

Quantum computing uses subatomic particles, such as electrons or photons to perform calculations that would normally take millions of years.

Instead of a normal computer bit, which utilizes zeros and ones, the quantum computer qubit can be in multidimensional state, allowing for an enormous amount of additional transactions,

Quantum computing can be used in many areas, including artificial intelligence, analyzing big data, the security industry, finance, military, drug design, aerospace, and much more.

According to McKinsey & Co., “Quantum computing now has the potential to capture nearly $700 billion in value as early as 2035, with that market estimated to exceed $90 billion annually by 2040.”

There are really only a couple of pure play stocks in the quantum computing arena, and both of them are very low cap companies.

Arqit Quantum Inc. (ARQQ), based in London, England, has a system called QuantumCloud which creates unbreakable software encryption keys.

The company is actually generating a profit, trading at about five times trailing earnings.

In addition, the company is debt-free, and even has 71 cents in cash per share. That may not seem like a lot, but it is a substantial percentage of the stock price of $2.50 per share, where it closed last Friday.

The stock has an extremely low cap of $307 million.

IonQ Inc. (IONQ) is the other option. The company, based in College Park, Maryland, develops general purpose quantum computing systems.

It is currently generating negative earnings. However, it is debt free and has $2.01 in cash per share at a recent stock price of $5.50 per share.

The stock has a market cap of $1.1 billion.

Let’s see if either of these stocks make a quantum leap.

Disclosure: Author didn’t own any of the above at the time the article was written.

Top Artificial Intelligence Stocks

by Fred Fuld III

So what is artificial intelligence?

It is perceiving, synthesizing, and inferring information demonstrated by machines, as opposed to intelligence displayed by humans.

It usually involves the use of big data, which is basically an enormous amount of information that is too large or complex to be dealt with by traditional database software.

According to Fortune Business Insights, the global AI market size is projected to grow from $387.45 billion in 2022 to $1394.30 billion in 2029 at a compound annual growth rate of 20.1% in the forecast period.

Precedence Research said that the artificial intelligence market size is expected to be over $1.5 trillion by the year 2030.

AI has many uses including deep learning, software development, advertising and the media.

In case you haven’t head by now, AI can be used to create an article from just a simple one sentence request.

You can see an example of this at OpenAI ChatGBT.

Here is a poem example:

In addition, OpenAI can create images and art from a simple suggestion.

So how does an investor participate?

All the major tech companies use AI in some fashion, but there are a few purer plays. Here are a few stocks that utilize big data and artificial intelligence in a big way.

• C3.ai (AI)

• Palantir (PLTR)

• MongoDB (MDB)

• Palo Alto Networks (PANW)

• Verint Systems Inc. (VRNT)

C3.ai (AI), which has a great stock ticker symbol, is probably the purest play in the AI arena. The company produces AI software with multiple commercial uses:

– energy management

– predictive maintenance

– fraud detection

cyber security

– anti-money laundering

– inventory optimization

– predictive CRM

C3.ai has a $1.86 billion market cap and unfortunately is currently generating negative earnings. Quarterly revenue growth is up 7% year over year. The company is debt free and has $8.98 in cash per share.

Please note that the stock has doubled during the last month.

Hopefully , you can add some intelligence to you portfolio.

Disclosure: Author owns PLTR.